The spatiotemporal associations between esophageal and gastric cancers provide evidence for its joint endoscopic screening in China: a population-based study
- PMID: 39232729
- PMCID: PMC11375892
- DOI: 10.1186/s12916-024-03594-7
The spatiotemporal associations between esophageal and gastric cancers provide evidence for its joint endoscopic screening in China: a population-based study
Abstract
Background: The spatiotemporal epidemiological evidence supporting joint endoscopic screening for esophageal cancer (EC) and gastric cancer (GC) remains limited. This study aims to identify combined high-risk regions for EC and GC and determine optimal areas for joint and separate endoscopic screening.
Methods: We analyzed the association of incidence trends between EC and GC in cancer registry areas across China from 2006 to 2016 using spatiotemporal statistical methods. Based on these analyses, we divided different combined risk regions for EC and GC to implement joint endoscopic screening.
Results: From 2006 to 2016, national incidence trends for both EC and GC showed a decline, with an average annual percentage change of -3.15 (95% confidence interval [CI]: -5.33 to -0.92) for EC and -3.78 (95% CI: -4.98 to -2.56) for GC. A grey comprehensive correlation analysis revealed a strong temporal association between the incidence trends of EC and GC, with correlations of 79.00% (95% CI: 77.85 to 80.14) in males and 77.62% (95% CI: 76.50 to 78.73) in females. Geographic patterns of EC and GC varied, demonstrating both homogeneity and heterogeneity across different regions. The cancer registry areas were classified into seven distinct combined risk regions, with 33 areas identified as high-risk for both EC and GC, highlighting these regions as priorities for joint endoscopic screening.
Conclusion: This study demonstrates a significant spatiotemporal association between EC and GC. The identified combined risk regions provide a valuable basis for optimizing joint endoscopic screening strategies for these cancers.
Keywords: China; Endoscopic screening; Esophageal cancer; Gastric cancer; Spatiotemporal association.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Spatiotemporal Correlation Analysis for the Incidence of Esophageal and Gastric Cancer From 2010 to 2019: Ecological Study.JMIR Cancer. 2025 Jan 29;11:e66655. doi: 10.2196/66655. JMIR Cancer. 2025. PMID: 39885591 Free PMC article.
-
Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time.Gut. 2023 May;72(5):846-854. doi: 10.1136/gutjnl-2022-328233. Epub 2022 Oct 14. Gut. 2023. PMID: 36241389
-
Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based Study.Am J Epidemiol. 2019 Apr 1;188(4):776-784. doi: 10.1093/aje/kwy291. Am J Epidemiol. 2019. PMID: 30608546
-
Screening high-risk populations for esophageal and gastric cancer.J Surg Oncol. 2019 Oct;120(5):831-846. doi: 10.1002/jso.25656. Epub 2019 Aug 1. J Surg Oncol. 2019. PMID: 31373005 Review.
-
Relationship between alcohol consumption and the risks of liver cancer, esophageal cancer, and gastric cancer in China: Meta-analysis based on case-control studies.Medicine (Baltimore). 2021 Aug 20;100(33):e26982. doi: 10.1097/MD.0000000000026982. Medicine (Baltimore). 2021. PMID: 34414976 Free PMC article. Review.
Cited by
-
Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021.Biomark Res. 2025 Jan 6;13(1):3. doi: 10.1186/s40364-024-00718-2. Biomark Res. 2025. PMID: 39762900 Free PMC article.
-
Identification and validation of serum MUC17 as a non-invasive early warning biomarker for screening of gastric intraepithelial neoplasia.Transl Oncol. 2025 Jan;51:102207. doi: 10.1016/j.tranon.2024.102207. Epub 2024 Nov 23. Transl Oncol. 2025. PMID: 39580962 Free PMC article.
References
-
- Wang S, Zheng R, Li J, Zeng H, Li L, Chen R, et al. Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN. The Lancet Gastroenterology & Hepatology. 2024;9:229–37. 10.1016/S2468-1253(23)00366-7 - DOI - PMC - PubMed
-
- World Health Organization. Cancer Today. 2022. https://gco.iarc.who.int/today/.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous